Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF MAY 21, 2023 SAM #7845
SOLICITATION NOTICE

65 -- BIOLEGEND TOTALSEQ ANTIBODIES FOR SINGLE CELLASSAYS (AMBIS 2175200)

Notice Date
5/19/2023 3:01:29 PM
 
Notice Type
Presolicitation
 
NAICS
325414 — Biological Product (except Diagnostic) Manufacturing
 
Contracting Office
NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
 
ZIP Code
20892
 
Solicitation Number
NOI-NIAID-23-2175200
 
Response Due
5/26/2023 8:00:00 AM
 
Point of Contact
RITA DAVIS, Phone: 3017617461, Tonia Alexander, Phone: 2406695124
 
E-Mail Address
RITA.DAVIS@NIH.GOV, talexander@niaid.nih.gov
(RITA.DAVIS@NIH.GOV, talexander@niaid.nih.gov)
 
Description
This is a Notice of Intent, not a request for proposal.� The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Biolegend, Inc., 8999 Biolegend Way, San Diego, CA 92121-3719, USA to procure TOTALSEQ antibodies for single cell assays in COVID related research. COVID-19 is caused by the novel SARS-CoV-2 and is associated with a hyper-inflammatory immune response which leads to severe and potentially life-threatening symptoms. Little is known about how and the extent to which COVID-19 presents in people with immunodeficiencies, but because of the known severity of the illness in the general population, vaccination against SARS-CoV-2 is critical. Understanding whether immunodeficient individuals produce an adequate immune response to the COVID-19 vaccine is necessary. These items (all of which are antibodies and associated solutions to make the antibodies work in experiments) are used to perform single-cell assays, which allow us to target specific immune cells that we are interested in studying. This work involves subjects who have recovered from COVID-19 and age- and sex-matched healthy controls who never had COVID-19. The purpose of this work is to understand how prior COVID-19 impacts the immune system long-term, including how the immune system responds to vaccination. The use of alternate antibodies would require a significant loss of productivity while we readapt our protocols, and would not allow us to obtain data comparable to the data we have already obtained using the existing reagents in the lab. Where: Laboratory of Immune System Biology, Sparks Lab, Building 4, room 128 When: upon receipt until reagents are exhausted. The current requirement is for: # DESCRIPTION CATALOG QTY 1 TotalSeq�-A 0251 anti-human Hashtag 1, ITEM 394601, 2 each 2 TotalSeq�-A 0252 anti-human Hashtag 2, ITEM 394603, 2 each 3 TotalSeq�-A 0253 anti-human Hashtag 3, ITEM 394605, 2 each 4 TotalSeq�-A 0254 anti-human Hashtag 4, ITEM 394607, 2 each 5 TotalSeq�-A Human Universal Cocktail, V1.0, ITEM 399907, 4 each 6 TotalSeq�-C 0253 anti-human Hashtag 3, ITEM 394665, 2 each 7 TotalSeq�-C 0254 anti-human Hashtag 4, ITEM 394667, 2 each 8 TotalSeq�-C Human Universal Cocktail, V1.0, ITEM 399905, 4 each The Place of performance is NIH Building 4, $ Memorial Drive, Bethesda, MD� 20892. The statutory authority for this sole source requirement is 41 U.S.C.1901 (e) (2) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.� All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-23-2175200) to Rita Davis at rita.davis@nih.gov by 11:00 am eastern standard time, Friday, May 26, 2023.� All responses received by the closing date of this synopsis will be considered by the Government.� A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/b0b8a64d931d493a949607b9e2f5336d/view)
 
Place of Performance
Address: Bethesda, MD 20892, USA
Zip Code: 20892
Country: USA
 
Record
SN06689064-F 20230521/230519230113 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.